[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection and …, 2020 - Elsevier
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection …, 2020 - ksascholar.dri.sa
Background: The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of infection …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

In silico molecular docking: evaluation of coumarin based derivatives against SARS-CoV-2.

SK Chidambaram, D Ali, S Alarifi, S Radhakrishnan… - 2020 - cabidigitallibrary.org
Background: The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection …, 2020 - europepmc.org
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection …, 2020 - ncbi.nlm.nih.gov
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …